[ad_1] AstraZeneca has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business. The upfront cash…
Tag: Biotechnologies
Fujifilm Diosynth Biotechnologies Unveils Strategic Customer-Focused Business Structure
[ad_1] FUJIFILM Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses, disclosed a new strategic business unit (SBU) structure to provide tailored…
FUJIFILM Diosynth Biotechnologies Announces Leadership Succession Appointment Upon Retirement of Site Head
[ad_1] COLLEGE STATION, TX – FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies and oncolytic viruses today announced that the College…
FUJIFILM Diosynth Biotechnologies Announces First Tenant for New Manufacturing Facility
[ad_1] HOLLY SPRINGS, N.C., November 7, 2023 – FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies announced that Janssen Supply…
FUJIFILM Diosynth Biotechnologies President and CEO Lars Petersen Appoints Dennis Schmidt Pedersen as Chief People Officer
[ad_1] Schmidt Pedersen is a seasoned executive with a proven track record of leading global teams through major transformation from business, organizational, cultural and leadership perspectives. He previously served as…
FUJIFILM Diosynth Biotechnologies Establishes New Strategic Business Structure
[ad_1] Officials at FUJIFILM Diosynth Biotechnologies say the CDMO has formed a new strategic business unit (SBU) structure to provide tailored support to large- and small-scale biopharmaceutical customers by aligning…
FUJIFILM Diosynth Biotechnologies Announces New Strategic, Customer-Focused Business Structure
[ad_1] Hillerød, Denmark and Research Triangle Park, North Carolina (August 24, 2023) – FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies and…
Fujifilm Appoints Lars Petersen as President & CEO of FUJIFILM Diosynth Biotechnologies, leading Global Bio CDMO
[ad_1] TOKYO – June 29, 2023 – FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that the company has appointed Lars Petersen as the new president and…